---
document_datetime: 2025-11-23 10:48:24
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/bropair-spiromax.html
document_name: bropair-spiromax.html
version: success
processing_time: 0.1091894
conversion_datetime: 2025-12-27 22:01:05.243942
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# BroPair Spiromax

[RSS](/en/individual-human-medicine.xml/67427)

##### Withdrawn

This medicine's authorisation has been withdrawn

salmeterol / fluticasone propionate

Medicine

Human

Withdrawn

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)
- [News on BroPair Spiromax](#news-on)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 23 May 2025, the European Commission withdrew the marketing authorisation for BroPair Spiromax (salmeterol / fluticasone propionate) in the European Union (EU). The withdrawal was at the request of the marketing authorisation holder, Teva B.V., which notified the European Commission of its decision not to market the product in the EU for commercial reasons.

BroPair Spiromax was granted marketing authorisation in the EU on 26 March 2021 for the treatment of asthma. The marketing authorisation was initially valid for a 5-year period. The product had not been marketed in the EU since 2024.

BroPair Spiromax was a duplicate application to Seffalair Spiromax, which is authorised in the EU to treat asthma and is marketed in several EU countries.

BroPair Spiromax : EPAR - Medicine overview

Reference Number: EMA/111494/2021

English (EN) (203.1 KB - PDF)

**First published:** 14/04/2021

**Last updated:** 30/06/2025

[View](/en/documents/overview/bropair-spiromax-epar-medicine-overview_en.pdf)

[Other languages (22)](#file-language-dropdown-521)

български (BG) (258.75 KB - PDF)

**First published:**

14/04/2021

**Last updated:**

30/06/2025

[View](/bg/documents/overview/bropair-spiromax-epar-medicine-overview_bg.pdf)

español (ES) (199.15 KB - PDF)

**First published:**

14/04/2021

**Last updated:**

30/06/2025

[View](/es/documents/overview/bropair-spiromax-epar-medicine-overview_es.pdf)

čeština (CS) (237.01 KB - PDF)

**First published:**

14/04/2021

**Last updated:**

30/06/2025

[View](/cs/documents/overview/bropair-spiromax-epar-medicine-overview_cs.pdf)

dansk (DA) (193.48 KB - PDF)

**First published:**

14/04/2021

**Last updated:**

30/06/2025

[View](/da/documents/overview/bropair-spiromax-epar-medicine-overview_da.pdf)

Deutsch (DE) (204.46 KB - PDF)

**First published:**

14/04/2021

**Last updated:**

30/06/2025

[View](/de/documents/overview/bropair-spiromax-epar-medicine-overview_de.pdf)

eesti keel (ET) (189.68 KB - PDF)

**First published:**

14/04/2021

**Last updated:**

30/06/2025

[View](/et/documents/overview/bropair-spiromax-epar-medicine-overview_et.pdf)

ελληνικά (EL) (265.19 KB - PDF)

**First published:**

14/04/2021

**Last updated:**

30/06/2025

[View](/el/documents/overview/bropair-spiromax-epar-medicine-overview_el.pdf)

français (FR) (201.7 KB - PDF)

**First published:**

14/04/2021

**Last updated:**

30/06/2025

[View](/fr/documents/overview/bropair-spiromax-epar-medicine-overview_fr.pdf)

hrvatski (HR) (226.13 KB - PDF)

**First published:**

14/04/2021

**Last updated:**

30/06/2025

[View](/hr/documents/overview/bropair-spiromax-epar-medicine-overview_hr.pdf)

italiano (IT) (209.82 KB - PDF)

**First published:**

14/04/2021

**Last updated:**

30/06/2025

[View](/it/documents/overview/bropair-spiromax-epar-medicine-overview_it.pdf)

latviešu valoda (LV) (239.84 KB - PDF)

**First published:**

14/04/2021

**Last updated:**

30/06/2025

[View](/lv/documents/overview/bropair-spiromax-epar-medicine-overview_lv.pdf)

lietuvių kalba (LT) (234.84 KB - PDF)

**First published:**

14/04/2021

**Last updated:**

30/06/2025

[View](/lt/documents/overview/bropair-spiromax-epar-medicine-overview_lt.pdf)

magyar (HU) (229.72 KB - PDF)

**First published:**

14/04/2021

**Last updated:**

30/06/2025

[View](/hu/documents/overview/bropair-spiromax-epar-medicine-overview_hu.pdf)

Malti (MT) (246.5 KB - PDF)

**First published:**

14/04/2021

**Last updated:**

30/06/2025

[View](/mt/documents/overview/bropair-spiromax-epar-medicine-overview_mt.pdf)

Nederlands (NL) (200.38 KB - PDF)

**First published:**

14/04/2021

**Last updated:**

30/06/2025

[View](/nl/documents/overview/bropair-spiromax-epar-medicine-overview_nl.pdf)

polski (PL) (237.82 KB - PDF)

**First published:**

14/04/2021

**Last updated:**

30/06/2025

[View](/pl/documents/overview/bropair-spiromax-epar-medicine-overview_pl.pdf)

português (PT) (200.58 KB - PDF)

**First published:**

14/04/2021

**Last updated:**

30/06/2025

[View](/pt/documents/overview/bropair-spiromax-epar-medicine-overview_pt.pdf)

română (RO) (236.68 KB - PDF)

**First published:**

14/04/2021

**Last updated:**

30/06/2025

[View](/ro/documents/overview/bropair-spiromax-epar-medicine-overview_ro.pdf)

slovenčina (SK) (234.27 KB - PDF)

**First published:**

14/04/2021

**Last updated:**

30/06/2025

[View](/sk/documents/overview/bropair-spiromax-epar-medicine-overview_sk.pdf)

slovenščina (SL) (226.1 KB - PDF)

**First published:**

14/04/2021

**Last updated:**

30/06/2025

[View](/sl/documents/overview/bropair-spiromax-epar-medicine-overview_sl.pdf)

Suomi (FI) (193.64 KB - PDF)

**First published:**

14/04/2021

**Last updated:**

30/06/2025

[View](/fi/documents/overview/bropair-spiromax-epar-medicine-overview_fi.pdf)

svenska (SV) (192.78 KB - PDF)

**First published:**

14/04/2021

**Last updated:**

30/06/2025

[View](/sv/documents/overview/bropair-spiromax-epar-medicine-overview_sv.pdf)

BroPair Spiromax : EPAR - Risk-management-plan summary

English (EN) (208.39 KB - PDF)

**First published:** 14/04/2021

**Last updated:** 30/06/2025

[View](/en/documents/rmp-summary/bropair-spiromax-epar-risk-management-plan-summary_en.pdf)

## Product information

BroPair Spiromax : EPAR - Product information

English (EN) (2.11 MB - PDF)

**First published:** 14/04/2021

**Last updated:** 30/06/2025

[View](/en/documents/product-information/bropair-spiromax-epar-product-information_en.pdf)

[Other languages (24)](#file-language-dropdown-447)

български (BG) (2.93 MB - PDF)

**First published:**

14/04/2021

**Last updated:**

30/06/2025

[View](/bg/documents/product-information/bropair-spiromax-epar-product-information_bg.pdf)

español (ES) (2.37 MB - PDF)

**First published:**

14/04/2021

**Last updated:**

30/06/2025

[View](/es/documents/product-information/bropair-spiromax-epar-product-information_es.pdf)

čeština (CS) (2.44 MB - PDF)

**First published:**

14/04/2021

**Last updated:**

30/06/2025

[View](/cs/documents/product-information/bropair-spiromax-epar-product-information_cs.pdf)

dansk (DA) (2.25 MB - PDF)

**First published:**

14/04/2021

**Last updated:**

30/06/2025

[View](/da/documents/product-information/bropair-spiromax-epar-product-information_da.pdf)

Deutsch (DE) (2.46 MB - PDF)

**First published:**

14/04/2021

**Last updated:**

30/06/2025

[View](/de/documents/product-information/bropair-spiromax-epar-product-information_de.pdf)

eesti keel (ET) (2.26 MB - PDF)

**First published:**

14/04/2021

**Last updated:**

30/06/2025

[View](/et/documents/product-information/bropair-spiromax-epar-product-information_et.pdf)

ελληνικά (EL) (3.22 MB - PDF)

**First published:**

14/04/2021

**Last updated:**

30/06/2025

[View](/el/documents/product-information/bropair-spiromax-epar-product-information_el.pdf)

français (FR) (2.52 MB - PDF)

**First published:**

14/04/2021

**Last updated:**

30/06/2025

[View](/fr/documents/product-information/bropair-spiromax-epar-product-information_fr.pdf)

hrvatski (HR) (2.53 MB - PDF)

**First published:**

14/04/2021

**Last updated:**

30/06/2025

[View](/hr/documents/product-information/bropair-spiromax-epar-product-information_hr.pdf)

íslenska (IS) (2.2 MB - PDF)

**First published:**

14/04/2021

**Last updated:**

30/06/2025

[View](/is/documents/product-information/bropair-spiromax-epar-product-information_is.pdf)

italiano (IT) (2.46 MB - PDF)

**First published:**

14/04/2021

**Last updated:**

30/06/2025

[View](/it/documents/product-information/bropair-spiromax-epar-product-information_it.pdf)

latviešu valoda (LV) (2.69 MB - PDF)

**First published:**

14/04/2021

**Last updated:**

30/06/2025

[View](/lv/documents/product-information/bropair-spiromax-epar-product-information_lv.pdf)

lietuvių kalba (LT) (2.59 MB - PDF)

**First published:**

14/04/2021

**Last updated:**

30/06/2025

[View](/lt/documents/product-information/bropair-spiromax-epar-product-information_lt.pdf)

magyar (HU) (2.55 MB - PDF)

**First published:**

14/04/2021

**Last updated:**

30/06/2025

[View](/hu/documents/product-information/bropair-spiromax-epar-product-information_hu.pdf)

Malti (MT) (2.86 MB - PDF)

**First published:**

14/04/2021

**Last updated:**

30/06/2025

[View](/mt/documents/product-information/bropair-spiromax-epar-product-information_mt.pdf)

Nederlands (NL) (2.33 MB - PDF)

**First published:**

14/04/2021

**Last updated:**

30/06/2025

[View](/nl/documents/product-information/bropair-spiromax-epar-product-information_nl.pdf)

norsk (NO) (2.23 MB - PDF)

**First published:**

14/04/2021

**Last updated:**

30/06/2025

[View](/no/documents/product-information/bropair-spiromax-epar-product-information_no.pdf)

polski (PL) (2.88 MB - PDF)

**First published:**

14/04/2021

**Last updated:**

30/06/2025

[View](/pl/documents/product-information/bropair-spiromax-epar-product-information_pl.pdf)

português (PT) (2.26 MB - PDF)

**First published:**

14/04/2021

**Last updated:**

30/06/2025

[View](/pt/documents/product-information/bropair-spiromax-epar-product-information_pt.pdf)

română (RO) (2.83 MB - PDF)

**First published:**

14/04/2021

**Last updated:**

30/06/2025

[View](/ro/documents/product-information/bropair-spiromax-epar-product-information_ro.pdf)

slovenčina (SK) (2.43 MB - PDF)

**First published:**

14/04/2021

**Last updated:**

30/06/2025

[View](/sk/documents/product-information/bropair-spiromax-epar-product-information_sk.pdf)

slovenščina (SL) (2.48 MB - PDF)

**First published:**

14/04/2021

**Last updated:**

30/06/2025

[View](/sl/documents/product-information/bropair-spiromax-epar-product-information_sl.pdf)

Suomi (FI) (2.4 MB - PDF)

**First published:**

14/04/2021

**Last updated:**

30/06/2025

[View](/fi/documents/product-information/bropair-spiromax-epar-product-information_fi.pdf)

svenska (SV) (2.22 MB - PDF)

**First published:**

14/04/2021

**Last updated:**

30/06/2025

[View](/sv/documents/product-information/bropair-spiromax-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** N/0000258678 01/04/2025

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

BroPair Spiromax : EPAR - All authorised presentations

English (EN) (100.51 KB - PDF)

**First published:** 14/04/2021

**Last updated:** 30/06/2025

[View](/en/documents/all-authorised-presentations/bropair-spiromax-epar-all-authorised-presentations_en.pdf)

[Other languages (24)](#file-language-dropdown-412)

български (BG) (121.33 KB - PDF)

**First published:**

14/04/2021

**Last updated:**

30/06/2025

[View](/bg/documents/all-authorised-presentations/bropair-spiromax-epar-all-authorised-presentations_bg.pdf)

español (ES) (105.46 KB - PDF)

**First published:**

14/04/2021

**Last updated:**

30/06/2025

[View](/es/documents/all-authorised-presentations/bropair-spiromax-epar-all-authorised-presentations_es.pdf)

čeština (CS) (112.06 KB - PDF)

**First published:**

14/04/2021

**Last updated:**

30/06/2025

[View](/cs/documents/all-authorised-presentations/bropair-spiromax-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (105.34 KB - PDF)

**First published:**

14/04/2021

**Last updated:**

30/06/2025

[View](/da/documents/all-authorised-presentations/bropair-spiromax-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (108.16 KB - PDF)

**First published:**

14/04/2021

**Last updated:**

30/06/2025

[View](/de/documents/all-authorised-presentations/bropair-spiromax-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (104.2 KB - PDF)

**First published:**

14/04/2021

**Last updated:**

30/06/2025

[View](/et/documents/all-authorised-presentations/bropair-spiromax-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (128.88 KB - PDF)

**First published:**

14/04/2021

**Last updated:**

30/06/2025

[View](/el/documents/all-authorised-presentations/bropair-spiromax-epar-all-authorised-presentations_el.pdf)

français (FR) (110.09 KB - PDF)

**First published:**

14/04/2021

**Last updated:**

30/06/2025

[View](/fr/documents/all-authorised-presentations/bropair-spiromax-epar-all-authorised-presentations_fr.pdf)

hrvatski (HR) (111.54 KB - PDF)

**First published:**

14/04/2021

**Last updated:**

30/06/2025

[View](/hr/documents/all-authorised-presentations/bropair-spiromax-epar-all-authorised-presentations_hr.pdf)

íslenska (IS) (109.94 KB - PDF)

**First published:**

14/04/2021

**Last updated:**

30/06/2025

[View](/is/documents/all-authorised-presentations/bropair-spiromax-epar-all-authorised-presentations_is.pdf)

italiano (IT) (103.52 KB - PDF)

**First published:**

14/04/2021

**Last updated:**

30/06/2025

[View](/it/documents/all-authorised-presentations/bropair-spiromax-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (125.93 KB - PDF)

**First published:**

14/04/2021

**Last updated:**

30/06/2025

[View](/lv/documents/all-authorised-presentations/bropair-spiromax-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (129.83 KB - PDF)

**First published:**

14/04/2021

**Last updated:**

30/06/2025

[View](/lt/documents/all-authorised-presentations/bropair-spiromax-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (115.09 KB - PDF)

**First published:**

14/04/2021

**Last updated:**

30/06/2025

[View](/hu/documents/all-authorised-presentations/bropair-spiromax-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (132.96 KB - PDF)

**First published:**

14/04/2021

**Last updated:**

30/06/2025

[View](/mt/documents/all-authorised-presentations/bropair-spiromax-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (102.01 KB - PDF)

**First published:**

14/04/2021

**Last updated:**

30/06/2025

[View](/nl/documents/all-authorised-presentations/bropair-spiromax-epar-all-authorised-presentations_nl.pdf)

norsk (NO) (106.65 KB - PDF)

**First published:**

14/04/2021

**Last updated:**

30/06/2025

[View](/no/documents/all-authorised-presentations/bropair-spiromax-epar-all-authorised-presentations_no.pdf)

polski (PL) (116.96 KB - PDF)

**First published:**

14/04/2021

**Last updated:**

30/06/2025

[View](/pl/documents/all-authorised-presentations/bropair-spiromax-epar-all-authorised-presentations_pl.pdf)

português (PT) (103.33 KB - PDF)

**First published:**

14/04/2021

**Last updated:**

30/06/2025

[View](/pt/documents/all-authorised-presentations/bropair-spiromax-epar-all-authorised-presentations_pt.pdf)

română (RO) (105.29 KB - PDF)

**First published:**

14/04/2021

**Last updated:**

30/06/2025

[View](/ro/documents/all-authorised-presentations/bropair-spiromax-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (125.95 KB - PDF)

**First published:**

14/04/2021

**Last updated:**

30/06/2025

[View](/sk/documents/all-authorised-presentations/bropair-spiromax-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (115.05 KB - PDF)

**First published:**

14/04/2021

**Last updated:**

30/06/2025

[View](/sl/documents/all-authorised-presentations/bropair-spiromax-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (107.28 KB - PDF)

**First published:**

14/04/2021

**Last updated:**

30/06/2025

[View](/fi/documents/all-authorised-presentations/bropair-spiromax-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (104.7 KB - PDF)

**First published:**

14/04/2021

**Last updated:**

30/06/2025

[View](/sv/documents/all-authorised-presentations/bropair-spiromax-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine BroPair Spiromax Active substance

- salmeterol xinafoate
- fluticasone propionate

International non-proprietary name (INN) or common name

- salmeterol
- fluticasone propionate

Therapeutic area (MeSH) Asthma Anatomical therapeutic chemical (ATC) code R03AK06

### Pharmacotherapeutic group

Drugs for obstructive airway diseases

### Therapeutic indication

BroPair Spiromax is indicated in the regular treatment of asthma in adults and adolescents aged 12 years and older not adequately controlled with inhaled corticosteroids and 'as needed' inhaled short-acting ?? agonists.

## Authorisation details

EMA product number EMEA/H/C/005591 Marketing authorisation holder

Teva B.V.

Swensweg 5

Opinion adopted 28/01/2021 Marketing authorisation issued 26/03/2021 Withdrawal of marketing authorisation 23/05/2025 Revision 4

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

BroPair Spiromax : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (226.9 KB - PDF)

**First published:** 02/04/2025

**Last updated:** 30/06/2025

[View](/en/documents/procedural-steps-after/bropair-spiromax-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf)

BroPair Spiromax : EPAR - Procedural steps taken and scientific information after authorisation (archive)

English (EN) (186.43 KB - PDF)

**First published:** 27/08/2021

**Last updated:** 30/06/2025

[View](/en/documents/procedural-steps-after/bropair-spiromax-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf)

## Initial marketing authorisation documents

BroPair Spiromax : EPAR - Public assessment report

Adopted

Reference Number: EMA/CHMP/21349/2021

English (EN) (13.41 MB - PDF)

**First published:** 14/04/2021

**Last updated:** 30/06/2025

[View](/en/documents/assessment-report/bropair-spiromax-epar-public-assessment-report_en.pdf)

CHMP summary of positive opinion for BroPair Spiromax

Adopted

Reference Number: EMA/CHMP/52922/2021

English (EN) (214.73 KB - PDF)

**First published:** 01/02/2021

**Last updated:** 30/06/2025

[View](/en/documents/smop-initial/chmp-summary-positive-opinion-bropair-spiromax_en.pdf)

#### News on BroPair Spiromax

[Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 25-29 January 2021](/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-25-29-january-2021) 29/01/2021

**This page was last updated on** 30/06/2025

## Share this page

[Back to top](#main-content)